Login to Your Account

France Roundup

SpePharm Seeking €35M from BioAlliance Pharma

By James Etheridge

Wednesday, April 22, 2009

No Abstract


BioWorld International Correspondent

PARIS - SpePharm Holding BV plans to file a claim against BioAlliance Pharma SA for financial damages and losses of at least €35 million (US$45.3 million).

To continue reading subscribe now to BioWorld Asia (formerly International)

Learn More about BioWorld Asia (formerly International)

Already a subscriber? Sign In or Buy now to activate your subscription